Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of STERIS plc (NYSE:STE – Free Report) by 15.9% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,261,927 shares of the medical equipment provider’s stock after purchasing an additional 172,795 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned 1.28% of STERIS worth $257,585,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Avalon Trust Co purchased a new position in shares of STERIS during the 4th quarter valued at approximately $30,000. Human Investing LLC bought a new position in STERIS during the 4th quarter valued at $31,000. Anfield Capital Management LLC grew its holdings in STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider’s stock worth $37,000 after acquiring an additional 91 shares in the last quarter. Central Pacific Bank Trust Division grew its holdings in STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider’s stock worth $39,000 after acquiring an additional 76 shares in the last quarter. Finally, Manchester Capital Management LLC raised its stake in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider’s stock valued at $44,000 after purchasing an additional 137 shares in the last quarter. 94.69% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of research firms recently commented on STE. Piper Sandler lifted their price target on STERIS from $260.00 to $265.00 and gave the stock an “overweight” rating in a research note on Monday, February 3rd. Stephens reaffirmed an “overweight” rating and set a $240.00 target price on shares of STERIS in a report on Thursday, February 6th. Finally, JMP Securities reissued a “market outperform” rating and issued a $265.00 price target on shares of STERIS in a report on Thursday, February 6th. One analyst has rated the stock with a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $258.75.
STERIS Price Performance
NYSE STE opened at $223.03 on Thursday. The company has a 50-day moving average price of $221.95 and a two-hundred day moving average price of $221.61. The stock has a market cap of $21.91 billion, a price-to-earnings ratio of 47.35 and a beta of 0.92. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. STERIS plc has a 52 week low of $197.82 and a 52 week high of $248.24.
STERIS (NYSE:STE – Get Free Report) last posted its earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 EPS for the quarter, missing the consensus estimate of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Analysts forecast that STERIS plc will post 9.08 EPS for the current year.
STERIS Announces Dividend
The business also recently announced a quarterly dividend, which was paid on Friday, March 21st. Investors of record on Thursday, February 20th were given a $0.57 dividend. The ex-dividend date was Thursday, February 20th. This represents a $2.28 dividend on an annualized basis and a yield of 1.02%. STERIS’s dividend payout ratio is presently 48.41%.
About STERIS
STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.
Further Reading
- Five stocks we like better than STERIS
- How to Invest in Biotech Stocks
- Energy Transfer: Powering Data With Dividends and Diversification
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Qualcomm Stock Is Coiling for a Breakout
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STE – Free Report).
Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.